Search

Your search keyword '"Joseph, R.W."' showing total 11 results
Start Over Author "Joseph, R.W." Publication Year Range Last 10 years
11 results on '"Joseph, R.W."'

2. 1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

Author

Hamid, O., primary, Joshua, A.M., additional, Hwu, W-J., additional, Ribas, A., additional, Weber, J., additional, Daud, A.S., additional, Hodi, F.S., additional, Wolchok, J.D., additional, Mitchell, T.C., additional, Hersey, P., additional, Dronca, R., additional, Joseph, R.W., additional, Boutros, C., additional, Min, L., additional, Long, G.V., additional, Schachter, J., additional, Lin, J., additional, Ibrahim, N., additional, Carlino, M., additional, and Robert, C., additional

Published
2020
Full Text
View/download PDF

3. Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

Author

Duma, N., primary, Azzouqa, A.-G., additional, Yadav, S., additional, Hoversten, K., additional, Reed, C., additional, Sitek, A.N., additional, Lou, Y., additional, Molina, J., additional, Halfdanarson, T., additional, Leventakos, K., additional, Joseph, R.W., additional, Manochakian, R., additional, and Dronca, R., additional

Published
2018
Full Text
View/download PDF

4. Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study

Author

Necchi, A., primary, Joseph, R.W., additional, Loriot, Y., additional, Hoffman-Censits, J., additional, Perez-Gracia, J.L., additional, Petrylak, D.P., additional, Derleth, C.L., additional, Tayama, D., additional, Zhu, Q., additional, Ding, B., additional, Kaiser, C., additional, and Rosenberg, J.E., additional

Published
2017
Full Text
View/download PDF

6. IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)

Author

Powles, T., primary, McDermott, D.F., additional, Rini, B., additional, Motzer, R.J., additional, Atkins, M.B., additional, Fong, L., additional, Joseph, R.W., additional, Pal, S.K., additional, Ravaud, A., additional, Bracarda, S., additional, Rodriguez, C. Suarez, additional, Maio, M., additional, Gore, M., additional, Grünwald, V., additional, Staehler, M., additional, Qiu, J., additional, Thobhani, A., additional, Huseni, M., additional, Schiff, C., additional, and Escudier, B., additional

Published
2017
Full Text
View/download PDF

9. LBA39 - IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)

Author

Powles, T., McDermott, D.F., Rini, B., Motzer, R.J., Atkins, M.B., Fong, L., Joseph, R.W., Pal, S.K., Ravaud, A., Bracarda, S., Rodriguez, C. Suarez, Maio, M., Gore, M., Grünwald, V., Staehler, M., Qiu, J., Thobhani, A., Huseni, M., Schiff, C., and Escudier, B.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results